Larimar Therapeutics, Inc.

DB:ZA71 Stock Report

Market Cap: €373.2m

Larimar Therapeutics, Inc. Company Information

Larimar Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Larimar Therapeutics, Inc.
  • Ticker: ZA71
  • Exchange: DB
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$394.325m
  • Listing Market Cap: US$373.229m
  • Shares Outstanding: 63.81m
  • Website: https://www.larimartx.com

Number of Employees

Location

  • Larimar Therapeutics, Inc.
  • Three Bala Plaza East
  • Suite 506
  • Bala Cynwyd
  • Pennsylvania
  • 19004
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ZA71DB (Deutsche Boerse AG)YesCommon StockDEEURMay 2020
LRMRNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDMay 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 14:49
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.